Nestlé Defends Infant Formula Labels After FSSAI Action
- 1Nestlé India responded on 18 September 2026 to FSSAI action against its NAN Excella Pro and Lactogen Pro infant formula labels, asserting full regulatory compliance.
- 2The company states its labels were approved by an expert committee of the food regulator and meet all applicable norms.
- 3FSSAI issued show-cause notices to Nestlé and other infant nutrition brands for alleged violations of labelling and advertising regulations under the Infant Milk Substitutes Act.
- 4This regulatory action signals heightened government scrutiny of health and nutrition claims in infant food marketing across India.
- 5The case highlights the critical importance of regulatory compliance in sensitive product categories where marketing messaging faces stringent oversight.
FMCG giant asserts compliance as regulatory scrutiny on infant nutrition marketing intensifies in India.
Nestlé India found itself in the regulatory crosshairs this week as the Food Safety and Standards Authority of India (FSSAI) issued show-cause notices to the FMCG giant over labelling concerns for its infant nutrition products. On 18 September 2026, Nestlé issued a strong rebuttal, asserting that its NAN Excella Pro and Lactogen Pro labels are "fully compliant" with all applicable regulations and were approved by an expert committee of the food regulator itself. The controversy marks another chapter in India's increasingly stringent oversight of infant nutrition marketing, with significant implications for how brands navigate the complex regulatory landscape in this sensitive category.
The Regulatory Action and Nestlé's Defence
FSSAI's show-cause notices targeted multiple infant nutrition brands, including Nestlé's flagship products, for alleged violations of labelling and advertising regulations under the Infant Milk Substitutes, Feeding Bottles and Infant Foods (Regulation of Production, Supply and Distribution) Act, 1992, and associated rules. Nestlé's response emphasizes that the company's labels underwent rigorous scrutiny by FSSAI's own expert committee before approval, suggesting a potential disconnect between different arms of the regulatory apparatus. The company maintains that all health claims, nutritional information, and marketing language on NAN Excella Pro and Lactogen Pro packaging comply with both IMS Act provisions and FSSAI labelling standards. This regulatory action comes at a time when infant formula brands face unprecedented scrutiny globally over marketing practices, particularly claims that could undermine breastfeeding advocacy.
Implications for Health and Nutrition Marketing
The infant nutrition category operates under some of the most restrictive marketing regulations in India, reflecting government priorities around public health and breastfeeding promotion. The IMS Act prohibits advertising of infant milk substitutes and imposes strict controls on labelling to prevent any messaging that could be construed as discouraging breastfeeding. For marketers in this space, the regulatory tightrope has become increasingly narrow. Even claims that appear factual or science-based can attract regulatory action if deemed to position formula feeding as equivalent or superior to breastfeeding. The current action suggests FSSAI is taking a more aggressive enforcement stance, potentially reviewing previously approved labels with fresh scrutiny. This creates uncertainty for brands that invested significant resources in securing regulatory approvals, only to face subsequent challenges to the same packaging and claims.
The Broader Context of Regulatory Intensity
This development reflects a wider trend of regulatory intensification across FMCG categories in India. From misleading advertising investigations by the Advertising Standards Council of India (ASCI) to consumer protection actions by state authorities, brands face a multi-layered compliance environment where standards continue to evolve. The infant nutrition sector's experience serves as a cautionary tale for marketers in adjacent health and wellness categories including baby food, health supplements, and functional foods. Regulatory authorities are increasingly willing to challenge industry practices that were previously tolerated, creating compliance risk even for established products with long market histories. The political economy context matters too: with India's 2026 general elections on the horizon, consumer protection and public health have become high-visibility political issues, potentially driving more aggressive regulatory postures across multiple agencies.
The Marketing and Reputational Stakes
For Nestlé India, the reputational dimensions of this controversy extend beyond the immediate regulatory challenge. The company has faced persistent criticism from public health advocates over infant formula marketing practices globally, making it particularly vulnerable to negative narratives around regulatory violations. In the age of social media amplification, regulatory actions quickly become brand reputation crises, especially in categories involving infant and child health where consumer sentiment runs deep. The company's emphatic assertion of compliance represents not just legal defence but reputation management, seeking to reassure both regulators and consumers of its commitment to responsible marketing. However, the very fact of receiving show-cause notices creates a perception problem that may require sustained communication efforts to address. For competitor brands also named in FSSAI's action, similar reputation challenges loom, potentially creating category-wide consumer trust issues.
This regulatory action against Nestlé and other infant nutrition brands illuminates a fundamental tension in Indian marketing: the gap between technical regulatory compliance and evolving interpretations of what constitutes responsible marketing in sensitive categories. Nestlé's claim that its labels were expert-committee-approved highlights a critical challenge—regulatory approval at one point doesn't guarantee immunity from subsequent enforcement action. This creates a compliance environment characterized by moving goalposts, where brands must adopt not just minimal legal compliance but anticipatory risk management strategies. Marketing and legal teams need to work in lockstep, conducting ongoing horizon scanning for regulatory sentiment shifts and maintaining documentation trails that demonstrate good-faith compliance efforts.
The infant nutrition controversy also signals that FMCG brands across categories should prepare for a more adversarial regulatory environment. As government agencies face public and political pressure to demonstrate consumer protection credentials, enforcement actions become more frequent and aggressive. The playbook for navigating this environment requires several elements: over-compliance rather than minimum compliance; proactive engagement with regulators before launching campaigns or packaging changes; robust scientific substantiation for all claims; and crisis communication preparedness for when regulatory challenges emerge. Brands that treat compliance as a checklist exercise rather than a strategic priority will find themselves increasingly vulnerable.
The Nestlé-FSSAI controversy reinforces that regulatory compliance in sensitive product categories is not a one-time achievement but an ongoing strategic imperative requiring constant vigilance. Marketers must recognize that approved claims can face fresh scrutiny as regulatory interpretations evolve, particularly in politically sensitive categories like infant nutrition, health foods, and wellness products. The smart approach combines defensive risk management—maintaining exhaustive compliance documentation, engaging legal counsel early in creative development, and monitoring regulatory sentiment—with proactive stakeholder engagement to stay ahead of enforcement trends. In an environment where brand reputation can be damaged more quickly than it can be rebuilt, treating regulatory compliance as a core marketing capability rather than a legal afterthought has become non-negotiable for brand leaders across India's FMCG landscape.
This article is an editorial rewrite based on reporting originally published by ThePrint. The original article has been rewritten and contextualised for India's marketing community by The Wise Marketing Desk using AI-assisted editorial tools.
Read original article at ThePrintFound this useful? Share it with your network.
Get India's best marketing news, daily.
Join 5,000+ marketing professionals reading The Wise Marketing.